Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

Current situation in gynecological oncology training in Spain: where we are and where we want to go

31-ago-2017 | Revista: Clinical & Translational Oncology

Padilla-Iserte P (1), Minig L (2), Zapardiel I (3), Chiva L (4), Laky R (5), de Santiago J (6). (1) Department of Gynecologic Oncology, Hospital Universitario La Fe, Avenida Abril Martorell, 106, 46026, Valencia, Spain.
(2) Department of Gynecologic Oncology, Hospital Universitario La Fe, Avenida Abril Martorell, 106, 46026, Valencia, Spain.
(3) Gynecologic Oncology Unit, La Paz University Hospital, Paseo Castellana 261, 28046, Madrid, Spain.
(4) Department of Obstetrics and Gynecology, Clinica Universidad de Navarra, Avenida de Pío XII, 36, 31008, Pamplona, Spain.
(5) Division of Gynecology, Medical University Graz, Auenbruggerplatz 14, 8036, Graz, Austria.
(6) Department of Gynecology Oncology, MD Anderson Cancer Center Madrid, Calle de Arturo Soria, 270, 28033, Madrid, Spain.


BACKGROUND:
It is important to know what a young gynecologic oncologist perceives as a need to achieve a good training in gynecologic oncology.

OBJECTIVE:
This study aims to evaluate the level of training in gynecologic oncology in Spain.

METHODS:
A Web-based anonymous questionnaire was sent via e-mail to Spanish trainees listed in European Network of Young Gynecological Oncology (ENYGO).

The survey was developed in four sections: (1) general training in gynecologic oncology, (2) distribution of current clinical activity, (3) surgical training, and (4) perspective future gynecologic oncology. It contained 51 questions, with multiple-choice answers that had to be answered by the ENYGO members.

RESULTS:
The questionnaire was sent to 64 people listed in the ENYGO database. Of these, 37 members responded (response rate of 58%). Overall, more training in surgery is necessary, to perform radical oncological surgeries. It is claimed a sub-specialty recognition, to ensure an equalitarian and homogeneous training.

CITA DEL ARTÍCULO  Clin Transl Oncol. 2017 Aug 31. doi: 10.1007/s12094-017-1744-9